会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 25. 发明授权
    • Therapy module crosstalk mitigation
    • 治疗模块串扰减轻
    • US08301263B2
    • 2012-10-30
    • US12363180
    • 2009-01-30
    • William T. DonofrioPaul G. KrauseGerald P. ArneJohn E. BurnesDavid J. PeichelXiaohong Zhou
    • William T. DonofrioPaul G. KrauseGerald P. ArneJohn E. BurnesDavid J. PeichelXiaohong Zhou
    • A61N1/00
    • A61N1/37288A61N1/36114
    • A first implantable medical device (IMD) implanted within a patient may communicate with a second IMD implanted within the patient by encoding information in an electrical stimulation signal. The delivery of the electrical stimulation signal may provide therapeutic benefits to the patient. The second IMD may sense the electrical stimulation signal, which may be presented as an artifact in a sensed cardiac signal, and process the sensed signal to retrieve the encoded information. The second IMD may modify its operation based on the received therapy information. Crosstalk between the first and second IMDs may be reduced using various techniques described herein. For example, the first IMD may generate the electrical stimulation signal to include a spread spectrum energy distribution or a predetermined signal signature. The second IMD may effectively remove a least some of the signal artifact in a sensed cardiac signal based on the predetermined signal signature.
    • 植入在患者体内的第一可植入医疗装置(IMD)可以通过对电刺激信号中的信息进行编码来与植入患者内的第二IMD进行通信。 电刺激信号的传递可以为患者提供治疗益处。 第二IMD可以感测电刺激信号,其可以被呈现为感测到的心脏信号中的伪像,并且处理感测到的信号以检索经编码的信息。 第二IMD可以基于接收到的治疗信息修改其操作。 可以使用本文所述的各种技术来减少第一和第二IMD之间的串扰。 例如,第一IMD可以产生电刺激信号以包括扩频能量分布或预定信号特征。 基于预定的信号签名,第二IMD可以有效地去除感测到的心脏信号中的至少一些信号伪像。
    • 26. 发明申请
    • THERAPY MODULE CROSSTALK MITIGATION
    • 治疗模块CROSSTALK减缓
    • US20100114189A1
    • 2010-05-06
    • US12363180
    • 2009-01-30
    • William T. DonofrioPaul G. KrauseGerald P. ArneJohn E. BurnesDavid J. PeichelXiaohong Zhou
    • William T. DonofrioPaul G. KrauseGerald P. ArneJohn E. BurnesDavid J. PeichelXiaohong Zhou
    • A61N1/36
    • A61N1/37288A61N1/36114
    • A first implantable medical device (IMD) implanted within a patient may communicate with a second IMD implanted within the patient by encoding information in an electrical stimulation signal. The delivery of the electrical stimulation signal may provide therapeutic benefits to the patient. The second IMD may sense the electrical stimulation signal, which may be presented as an artifact in a sensed cardiac signal, and process the sensed signal to retrieve the encoded information. The second IMD may modify its operation based on the received therapy information. Crosstalk between the first and second IMDs may be reduced using various techniques described herein. For example, the first IMD may generate the electrical stimulation signal to include a spread spectrum energy distribution or a predetermined signal signature. The second IMD may effectively remove a least some of the signal artifact in a sensed cardiac signal based on the predetermined signal signature.
    • 植入在患者体内的第一可植入医疗装置(IMD)可以通过对电刺激信号中的信息进行编码来与植入患者内的第二IMD进行通信。 电刺激信号的传递可以为患者提供治疗益处。 第二IMD可以感测电刺激信号,其可以被呈现为感测到的心脏信号中的伪像,并且处理感测到的信号以检索经编码的信息。 第二IMD可以基于接收到的治疗信息修改其操作。 可以使用本文所述的各种技术来减少第一和第二IMD之间的串扰。 例如,第一IMD可以产生电刺激信号以包括扩频能量分布或预定信号特征。 基于预定的信号签名,第二IMD可以有效地去除感测到的心脏信号中的至少一些信号伪像。